|
Company:
|
AGENUS INC (AGEN)
|
|
Form Type:
|
4
|
|
Filing Date:
|
3/20/2017
|
|
CIK:
|
0001098972
|
|
Address:
|
3 FORBES ROAD
|
|
City, State, Zip:
|
LEXINGTON, Massachusetts 02421
|
|
Telephone:
|
781-674-4410
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$2.43
|
Change:
-0.07 (-2.80%)
|
Trade Time:
Jun 22
|
Market Cap:
$252.72M
|
|
|
|
|
|
|
Description of Business
|
|
We are a clinical-stage immuno-oncology ("I-O") company dedicated to becoming a
leader in the discovery and development of innovative combination therapies and
committed to bringing effective medicines to patients with cancer. Our business
is designed to drive success in I-O through speed, innovation, and effective
combination therapies. We have assembled fully integrated capabilities from
novel target discovery, antibody generation, cell line development, and good
manufacturing practice ("GMP") manufacturing together with a comprehensive
portfolio consisting of antibody-based therapeutics, adjuvants and cancer
vaccine platforms. We leverage our immune biology platforms to identify
effective combination therapies for development and have developed productive
partnerships to advance our innovation.
|
|
|
|